Skip to main content
Top
Published in: Investigational New Drugs 3/1997

01-09-1997

Unusual central nervous system toxicity in a phase I study of N1N11diethylnorspermine in patients with advanced malignancy

Authors: Patrick J. Creaven, Raymond Perez, Lakshmi Pendyala, Neal J. Meropol, Gregory Loewen, Ellis Levine, Elmer Berghorn, Derek Raghavan

Published in: Investigational New Drugs | Issue 3/1997

Login to get access
Metadata
Title
Unusual central nervous system toxicity in a phase I study of N1N11diethylnorspermine in patients with advanced malignancy
Authors
Patrick J. Creaven
Raymond Perez
Lakshmi Pendyala
Neal J. Meropol
Gregory Loewen
Ellis Levine
Elmer Berghorn
Derek Raghavan
Publication date
01-09-1997
Publisher
Kluwer Academic Publishers
Published in
Investigational New Drugs / Issue 3/1997
Print ISSN: 0167-6997
Electronic ISSN: 1573-0646
DOI
https://doi.org/10.1023/A:1005827231849

Other articles of this Issue 3/1997

Investigational New Drugs 3/1997 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine